ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 669

Assessment of Spinal Mobility in Axial Spondyloarthritis: First Validation Steps of a New Electronic Quantification Tool

Xenofon Baraliakos, David Kiefer, Susanne Herbold and Jürgen Braun, Rheumazentrum Ruhrgebiet, Herne, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS) and functional status

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Spondylarthropathies and Psoriatic Arthritis - Clinical Aspects and Treatment Poster I: Clinical Aspects and Assessments

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Spinal mobility is a major health issue of patients with axial spondyloarthritis (axSpA), especially in ankylosing spondylitis (AS) while non-radiographic axSpA (nr-axSpA) has been less well studied in this regard. The available tools such as the BASMI and, indirectly, also the BASFI have limitations in exactly quantifying spinal mobility. In this study, we evaluate the performance of a newly developed electronic tool to measure spinal mobility.

Methods: Consecutive patients with axSpA, mechanical back pain and healthy controls were examined by the Epionics spine device (ESp), a novel electronic system, which measures the range of motion (ROM) for spinal mobility using non-invasive angle sensor strips in 12 evenly spaced locations along the spine. ESp has been shown to reliably measure the ROM for all domains of spinal mobility (flexion, extension, rotation and combinations). Physical examinations (BASMI), questionnaires (BASFI) and a recently proposed tool to assess function (ASPI, 1) were performed in parallel. The assessors were unaware of the results of the other tests. The time to use the device was measured. Statistical comparisons between groups were performed with the Mann-Whitney-U-test.

Results: A total of 65 patients with axSpA (38 (58%) with AS and 27 (42%) with nr-axSpa), 48 patients with mechanical back pain (mBP) and 20 healthy controls (HC) were included in this prospective study. The BASFI and BASMI values were generally higher in patients with AS (4.1±2.3 and 2.7±2.3) vs. nr-axSpA (3.8±1.9 and 1.2±1.0), mBP (4.0±2.4 and 1.3±1.1) and HC (0.5±0.7 and 0.6±0.8). Using ESp, the measured range of ROM AS patients performed worse in all aspects (Table). The mean duration of performance of ESp was 12±3 minutes.

Spinal flexion

Spinal extension

Rotation to left

Rotation to right

Lateral flexion to left

Lateral flexion to right

Flexion and rotation from left to right

Extension and rotation from left to right

Flexion and rotation from right to left

Extension and rotation from right to left

AS

Mean

39,2

16,4

20,2

21,4

16,1

17,0

31,7

5,6

33,3

5,7

SD

17,2

12,9

9,7

9,0

8,8

9,5

16,8

5,4

16,6

5,2

nr-axSpA

Mean

46,5

21,6

26,2

24,8

21,6

23,0

39,3

7,2

39,8

6,9

SD

14,2

9,6

9,2

8,7

7,1

7,1

14,6

4,6

13,0

5,9

p-value nr-axSpA vs. AS

0,124

0,018

0,011

0,159

0,006

0,008

0,043

0,134

0,122

0,410

mBP

Mean

48,4

23,9

22,7

24,6

23,6

25,5

43,8

9,8

44,2

8,7

SD

13,0

12,0

10,0

9,7

7,9

7,1

13,2

7,7

12,5

7,6

p-value mBP vs. AS

0,033

0,001

0,266

0,214

0,001

0,001

0,001

0,010

0,315

0,784

HC

Mean

51,6

28,2

26,8

27,9

30,4

30,9

45,9

10,1

47,7

10,4

SD

11,4

11,5

10,6

9,1

7,6

8,8

12,3

10,7

10,9

9,3

p-value HC vs. AS

0,007

0,001

0,033

0,022

0,001

0,000

0,004

0,245

0,318

0,722

Table: ROM (in angles) for the different patient subgroups

Conclusion: The Epionics spine device had good construct, content and face validity in this first study, which prospectively compared patients with axSpA, mechanical back pain and healthy volunteers. It will be interesting to study its correlation to single BASMI and BASFI items and to learn whether it provides higher sensitivity to change as compared to conventional assessments of spinal mobility and function.


Disclosure: X. Baraliakos, None; D. Kiefer, None; S. Herbold, None; J. Braun, None.

To cite this abstract in AMA style:

Baraliakos X, Kiefer D, Herbold S, Braun J. Assessment of Spinal Mobility in Axial Spondyloarthritis: First Validation Steps of a New Electronic Quantification Tool [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/assessment-of-spinal-mobility-in-axial-spondyloarthritis-first-validation-steps-of-a-new-electronic-quantification-tool/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-of-spinal-mobility-in-axial-spondyloarthritis-first-validation-steps-of-a-new-electronic-quantification-tool/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology